DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Compare the Success Rate of T3 Dental Implant (Biomet 3I) With or Without Platform-switch Concept

Information source: Instituto de Implantologia
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Implants; Bone Loss

Intervention: Dental Implant (Device); Platform-Switch Dental Implant (Device); Platform-Matched dental implant (Device)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Instituto de Implantologia

Official(s) and/or principal investigator(s):
Andre Chen, Msc, Principal Investigator, Affiliation: Instituto de Implantologia
João Caramês, Phd, Study Director, Affiliation: Instituto de Implantologia
Helena Francisco, Msc, Study Chair, Affiliation: Instituto de Implantologia
Elena Cervino, Msc, Study Chair, Affiliation: Instituto de Implantologia

Overall contact:
André Chen, Msc, Phone: 00351919774343, Email: tsouchen@gmail.com

Summary

In patients that received a T3 (Biomet 3I) dental implant, does the use of platform-switch concept compared to the use of platform-matched concept, refrain marginal bone loss during osseointegration phase (t=12 weeks =T1) and from then to final rehabilitation (t= placement of the final restoration = at 18 weeks=T2)

Clinical Details

Official title: Marginal Bone Behavior of Dental Implants to Different Rehabilitation Protocols

Study design: Observational Model: Case Control, Time Perspective: Cross-Sectional

Primary outcome:

Position of Implant Platform to marginal bone

Marginal Bone Position at 8 Weeks

Marginal Bone Position at 12 Weeks

Secondary outcome: Osseointegration

Detailed description: Patients from a private practice who received dental implants (T3 dental implant Biomet 3I) from November 2012 to October 2013 were eligible to enter the study. Two groups were formed: one group received a T3 dental implant with platform switch concept and the other received an implant with platform matched type of connection. We evaluate osseointegration at T1 (12 weeks) and marginal bone position in relation to the implant platform at baseline (implant installation) T0 and again at T1 and T2. From data recorder in T0,T1 and T2, we evaluate changes in marginal bone position.

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Single unit implant rehabilitation

- Maxilla and mandible

- Biomet 3I T3 dental implant placed

- Final Rehabilitation placed

Exclusion Criteria:

- Immediate implants

- Radiographic impossibility of measure

- Absence of baseline T0 radiograph

- Smoking habits (more 10 cigarets a day)

- Diabetes

- Patients who receive Radio or/and Chemotherapy

Locations and Contacts

André Chen, Msc, Phone: 00351919774343, Email: tsouchen@gmail.com

Instituto de Implantologia, Lisbon 1500-662, Portugal; Not yet recruiting
Joana Velez, Email: joana.velez@institutodeimplantologia.com
Andre Chen, Msc, Principal Investigator
João Caramês, Msc, Principal Investigator
Helena Francisco, Msc, Principal Investigator
Elena Cervino, Msc, Sub-Investigator
Additional Information

Starting date: January 2014
Last updated: October 23, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017